Steven Lo
Chief Executive Officer chez VAXART, INC.
Fortune : 325 000 $ au 31/03/2024
Profil
Mr. Steven Lo is a President, Chief Executive Officer & Director at Vaxart, Inc. He is on the Board of Directors at Vaxart, Inc. Mr. Lo was previously employed as a Chief Executive Officer & Director by Valitor, Inc., a President, Chief Executive Officer & Director by Zosano Pharma Corp., a Chief Commercial Officer by Puma Biotechnology, Inc., a Chief Commercial Officer & Senior Vice President by Corcept Therapeutics, Inc., a Senior Director-Oncology Marketing by Genentech, Inc., and a Principal by Kaiser Permanente Washington Health Research Institute.
He received his undergraduate degree from the University of California, Davis and a graduate degree from the University of Southern California.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
VAXART, INC.
0,14% | 18/03/2024 | 250 000 ( 0,14% ) | 325 000 $ | 31/03/2024 |
Postes actifs de Steven Lo
| Sociétés | Poste | Début |
|---|---|---|
| VAXART, INC. | Chief Executive Officer | 18/03/2024 |
Anciens postes connus de Steven Lo
| Sociétés | Poste | Fin |
|---|---|---|
Valitor, Inc.
 Valitor, Inc. BiotechnologyHealth Technology Valitor, Inc. develops a new generation of biotechnology drugs. It develops methods of modifying therapeutic proteins to achieve substantial control over pharmacokinetics, target specificity and bioactivity. The company was founded by Kevin E. Healy, Wesley M. Jackson and David Schaffer in 2010 and is headquartered in Berkeley, CA. | Chief Executive Officer | 01/03/2024 |
| ZOSANO PHARMA CORPORATION | Chief Executive Officer | 01/08/2022 |
| PUMA BIOTECHNOLOGY, INC. | Corporate Officer/Principal | 04/10/2019 |
| CORCEPT THERAPEUTICS INCORPORATED | Corporate Officer/Principal | 04/09/2015 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
Formation de Steven Lo
| University of Southern California | Graduate Degree |
| University of California, Davis | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| CORCEPT THERAPEUTICS INCORPORATED | Health Technology |
| PUMA BIOTECHNOLOGY, INC. | Health Technology |
| VAXART, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Kaiser Permanente Washington Health Research Institute
 Kaiser Permanente Washington Health Research Institute Hospital/Nursing ManagementHealth Services Kaiser Permanente Washington Health Research Institute is a non profit organization that provides healthcare plans and services. It focuses on total health of its members and guided by personal physicians, specialists, and team of caregivers. Its expert and caring medical teams are empowered and supported by industry-leading technology advances and tools for health promotion, disease prevention, care delivery, and chronic disease management. The company was founded in 1983 and is headquartered in Seattle, WA. | Health Services |
Valitor, Inc.
Valitor, Inc. BiotechnologyHealth Technology Valitor, Inc. develops a new generation of biotechnology drugs. It develops methods of modifying therapeutic proteins to achieve substantial control over pharmacokinetics, target specificity and bioactivity. The company was founded by Kevin E. Healy, Wesley M. Jackson and David Schaffer in 2010 and is headquartered in Berkeley, CA. | Health Technology |
Zosano Pharma Corp.
 Zosano Pharma Corp. Pharmaceuticals: MajorHealth Technology Zosano Pharma Corp. is a clinical stage biopharmaceutical company, which engages in the development of human pharmaceutical products. It also focuses on providing rapid systemic administration of therapeutics to patients using proprietary intracutaneous microneedle system. The company was founded in October 2006 and is headquartered in Fremont, CA. | Health Technology |
